End-Stage Hip Osteoarthritis: From Joint Damage to Surgery

End-stage hip osteoarthritis is the final chapter of cartilage loss in the hip joint, the point at which the protective cushion between the femoral head and the acetabulum has worn away so thoroughly that bone grinds against bone. On an X-ray, the hallmarks are stark: the joint space is nearly or completely obliterated, large cysts have formed in the bone, the femoral head has lost its round shape, and bony spurs have grown to substantial size. At this stage, pain and stiffness typically dominate daily life, and total hip replacement becomes the most commonly discussed solution. But the path to end-stage disease, the biology driving it, and the decisions surrounding treatment are more layered than that summary suggests.

What Is Happening Inside the Joint

By the time hip osteoarthritis reaches its end stage, the articular cartilage that once allowed smooth, pain-free movement is largely gone. What remains is a cascade of changes in the bone beneath that cartilage. In areas where cartilage has been lost, the subchondral bone thickens and accumulates microdamage, tiny cracks that healthy bone would normally repair through remodeling. Research on femoral heads removed during hip replacement shows that this repair mechanism does not keep up. Instead, the bone volume in cartilage-loss areas increases through a different process, essentially adding mass in response to mechanical stress without effectively healing the microcracks.

The calcified cartilage layer, a thin zone between the soft cartilage and the hard bone, also changes. In primary osteoarthritis, this layer thickens as the body converts cartilage into bone through endochondral ossification. This thickening actually precedes the loss of the articular cartilage above it, suggesting it plays an active role in driving the disease forward rather than simply responding to it. The picture is different when osteoarthritis develops secondarily from an inflammatory condition like rheumatoid arthritis, where this calcified layer becomes severely thinned and cartilage loss is more widespread.

At a molecular level, enzymes responsible for breaking down cartilage are actively at work throughout the disease. One family of enzymes, the ADAMTS proteins, shows a striking pattern in end-stage hip osteoarthritis: certain members are elevated while others are paradoxically decreased, suggesting the balance of cartilage degradation and maintenance is thoroughly disrupted by this point.

How the Hip Reaches End Stage

Not every arthritic hip progresses to the end stage. When it does, the underlying cause often traces back to the shape of the joint itself. Two of the most recognized structural risk factors are hip dysplasia, where the socket is too shallow to properly cover the femoral head, and femoroacetabular impingement, where extra bone on the femur or acetabulum causes abnormal contact during movement.

⁴

These two conditions do not carry equal weight. A long-term study found that hips with developmental dysplasia developed degenerative changes earliest, while hips with impingement alone followed a timeline surprisingly similar to structurally normal hips. The combination of a cam-type impingement deformity with even mild acetabular dysplasia, though, accelerated the process considerably. This research suggested that correcting impingement surgically may have only a minimal impact on the natural history of the disease, especially once any cartilage damage has already begun.

⁵

Femoroacetabular impingement has been confirmed as a relevant factor across populations. In a Japanese cohort, impingement deformities were found in primary osteoarthritis cases at rates similar to those in Western populations, though they accounted for a smaller share of all hip failures.

⁶

Biomechanics also matter in a straightforward way: higher peak contact stress on the hip joint predicts faster disease progression and earlier surgery. The side of the body with higher contact stress tends to be the side that develops osteoarthritis first.

⁷

Excess body weight and an unfavorable pelvic geometry both increase that contact stress and are associated with needing a hip replacement at a younger age.

⁸

How End-Stage Disease Is Diagnosed and Graded

Clinically, hip osteoarthritis is identified through a combination of symptoms and physical exam findings. A classic presentation includes pain at the side or front of the hip during weight-bearing activities, morning stiffness that lasts less than an hour, and measurable loss of internal rotation and flexion when the affected hip is compared with the other side.

⁹

Staging the severity relies on X-rays. The Tönnis classification is one of the most widely used grading systems. It runs from Grade 0 (no signs of osteoarthritis) to Grade 3, which represents end-stage disease: large cystic changes in the bone, severe narrowing or complete obliteration of the joint space, severe deformity of the femoral head, and large osteophytes. The Kellgren-Lawrence system is another common grading scale, where grades 3 and 4 represent advanced disease.

¹⁰

One important wrinkle is that X-ray severity does not always match pain severity. Some people with mild radiographic changes report severe pain, while others with extensive bone-on-bone contact manage with moderate discomfort. This disconnect has real consequences for treatment decisions and will come up again later in this article.

What Conservative Treatment Can and Cannot Do at This Stage

By the time someone reaches end-stage disease, conservative management has typically been tried for months or years. The Osteoarthritis Research Society International published guidelines for non-surgical management of hip osteoarthritis that highlight exercise, weight management, and certain medications as core treatments. Interestingly, the guidelines do not recommend some treatments for hip osteoarthritis that work for knee osteoarthritis. Corticosteroid injections into the hip joint, hyaluronic acid injections, and aquatic exercise were not recommended for hip osteoarthritis despite being conditionally recommended for knee disease.

¹¹

That does not mean nothing helps. Oral pain medications, physical therapy to maintain range of motion and muscle strength, walking aids, and weight loss in people carrying extra weight can all reduce symptoms. But at the end stage, these measures generally offer diminishing returns. An analysis of costs in the year before hip replacement found that conservative treatments like steroid injections, physical therapy, and pain medications accounted for about 40 to 44 percent of total healthcare spending in that period, with a notable spike in opioid use and steroid injections in the final three months before surgery.

¹²

When Surgery Becomes the Right Call

Evidence-based guidelines recommend total hip replacement only when radiographs confirm advanced disease, at least three months of conservative treatment have been tried, and the patient reports high subjective distress from their symptoms.

¹³

A review of published indication criteria found that the decision consistently involves four domains: pain, functional limitation, radiographic changes, and failure of conservative therapy. Yet specific cut-off values or thresholds for when exactly to proceed are rarely defined, and the overall level of evidence behind these criteria remains low. In practice, the decision is heavily individualized, driven by how much the disease is affecting your life.

¹⁴

One common misconception is that you should “wait as long as possible” before getting a hip replacement. While it is true that implants have a finite lifespan and younger patients may eventually need a revision, waiting too long carries its own costs. Muscle wasting accelerates, compensatory movement patterns become more entrenched, and overall physical decline can make surgery harder and recovery slower.

Surgical Approaches and What Differs Between Them

If you proceed with total hip arthroplasty, the surgeon reaches the joint through one of several routes. The three most discussed are the direct anterior approach, the posterior approach, and the lateral approach. A meta-analysis comparing these found that the direct anterior approach takes longer in the operating room, roughly 17 minutes more than the posterior approach, but results in a slightly shorter hospital stay by about a third of a day. In early functional scores, the anterior approach showed a modest advantage at six weeks compared to the posterior approach, but these differences tend to even out by three months.

¹⁵

One finding that sometimes surprises patients is that the anterior approach, often marketed as “muscle-sparing” and less invasive, actually carried the highest complication rate in one large analysis, at about 8.5 percent, compared to roughly 5.9 percent for the posterior approach. The most common complications across all approaches were deep infection, fracture around the implant, and prolonged wound drainage.

¹⁶

No single approach is universally superior. The best choice depends on the surgeon’s experience and the patient’s anatomy. A separate meta-analysis found that early hip flexion and extension strength was actually lower in the anterior approach group at two and six weeks after surgery, which complicates the narrative of faster recovery.

¹⁷

Cemented Versus Cementless Implants

Another decision involves how the implant is fixed to your bone. Cemented fixation uses bone cement to anchor the components in place immediately, while cementless implants have a porous surface designed for your bone to grow into over time. A systematic review of randomized trials found no significant difference between the two in revision rates, mortality, or complication rates. Short-term pain scores were better with cemented fixation, but longer-term functional outcomes remain unclear.

¹⁸

The bearing surfaces, the materials where the ball meets the socket, have also evolved. A review of hard-on-hard bearing combinations found ceramic-on-ceramic implants survived at rates of 96 to 100 percent over periods of roughly four to eight years, while metal-on-metal designs showed similarly high short-term survival but have since fallen out of favor due to concerns about metal ion release.

¹⁹

Recovery and Long-Term Outcomes

Enhanced recovery after surgery protocols have transformed the experience of hip replacement. These programs emphasize preoperative education, multimodal pain management that reduces reliance on opioids, early mobilization, and careful fluid and nutritional support.

²⁰

In one program, patients with fewer medical comorbidities had average hospital stays of about 3.9 days for hip replacement, satisfaction was rated “very satisfied” in over 94 percent of cases, and about two-thirds of patients continued rehabilitation on their own at home without a professional physiotherapist.

²¹

Long-term follow-up studies show that patients remain broadly satisfied years after surgery, with satisfaction rates around 96 percent. Physical function scores after hip replacement are better than those of untreated severe osteoarthritis patients, although they do not typically reach the level of people who never had hip problems.

²²

Complication risk is influenced by patient factors including comorbidities, diabetes, advanced age, and male sex.

²³

Why Implants Eventually Fail

The most common reason a hip replacement eventually needs to be redone is aseptic loosening, accounting for roughly two-thirds of revision surgeries. Infection, bone loss around the implant, fracture near the prosthesis, and instability make up most of the rest.

²⁴

Aseptic loosening happens when microscopic wear particles shed from the implant’s bearing surfaces trigger a chronic inflammatory response. Immune cells react to these particles as foreign material, and the resulting inflammation gradually eats away at the bone holding the implant in place. Over a decade or more, this can destabilize the prosthesis enough to require revision.

²⁵

The Muscle Problem That Outlasts Surgery

One of the less discussed consequences of end-stage hip osteoarthritis is the damage it does to the muscles around the joint, particularly the gluteal muscles that stabilize the pelvis during walking. By the time someone reaches surgery, years of limping and reduced activity have usually caused significant atrophy and fatty infiltration of these muscles on the affected side. Research has shown that the condition of the gluteus medius and gluteus maximus before surgery directly predicts walking speed and functional performance afterward. More fatty infiltration in the smaller gluteal muscles and less lean muscle mass in the gluteus maximus both correlate with slower recovery.

²⁶

Perhaps more striking is how persistent this muscle deficit turns out to be. One study measured gluteus medius size before surgery and at follow-ups years later. The muscle on the formerly arthritic side remained significantly smaller than the muscle on the healthy side not just at three years, but even eight years after surgery.

²⁷

This is one of the strongest arguments for not delaying surgery until the muscles have deteriorated severely, and for prioritizing targeted hip strengthening both before and after the procedure.

When Pain Does Not Match the X-Ray

A frustrating reality of hip osteoarthritis is the poor correlation between what the X-ray shows and how much pain someone feels. Some patients with relatively mild radiographic disease experience debilitating pain, while others with severely deformed joints report more tolerable symptoms. Research has increasingly tied this discrepancy to central sensitization, a state in which the nervous system itself amplifies pain signals regardless of what is happening at the joint.

Studies of hip osteoarthritis patients have found that those with more widespread pain, beyond the hip itself, show signs of central sensitization: lower pain thresholds at body sites far from the hip, higher scores on questionnaires measuring catastrophic thinking about pain, and features of neuropathic-type pain.

²⁸

Patients who complained of severe pain despite less severe joint deformity were significantly more likely to show altered pain processing on quantitative sensory testing.

²⁹

This matters because central sensitization can persist after joint replacement. If the nervous system has been rewired to amplify pain, removing the damaged joint alone may not fully resolve the problem. Identifying and addressing centralized pain before surgery, through psychological approaches, pain-processing medications, or graded exercise, may improve post-surgical outcomes for these patients.

Stem Cell Therapies and the Question of Regeneration

For people hoping to avoid or delay surgery, stem cell injections have generated considerable interest. Scoping reviews of stem cell-based therapies for hip osteoarthritis report consistent short-to-mid-term pain reduction, with visual analog scale scores dropping by about 30 to 50 percent, along with functional improvements. Adverse events were rare and mild, limited mostly to temporary joint soreness and swelling.

³⁰

The problem is structural repair. Radiographic evidence of actual cartilage regrowth has been limited and inconsistent across studies. A narrative review of mesenchymal stem cell injections found that five out of six studies showed statistically significant improvement in patient-reported outcomes, but only two provided imaging data, and the evidence base consists entirely of small, non-randomized trials.

³¹

A separate scoping review of bone marrow-derived stem cell therapy found clinical benefit in all seven included studies but noted that all used low doses with variable follow-up times, making it impossible to establish a clear dose-response relationship.

³²

The honest summary: stem cell injections may help with pain and function for a while, but there is no reliable evidence they rebuild lost cartilage or change the disease trajectory. Randomized controlled trials are still needed before these therapies can be considered a genuine alternative to joint replacement in end-stage disease. If a clinic promises cartilage regeneration, be skeptical.

Robotic-Assisted Surgery

Robotic-arm-assisted hip replacement has gained traction as a way to improve implant positioning. A review of early clinical outcomes found that robotic-assisted total hip arthroplasty produced favorable short-term results without a higher complication rate compared to conventional surgery.

³³

A first-in-human study of a newer pinless robotic system demonstrated that acetabular cup placement was within five degrees of the target in about 78 percent of cases, and nearly all cups fell within the Lewinnek safe zone, the range of positions thought to minimize dislocation risk. At one year, pain scores dropped dramatically and functional scores roughly doubled, with about 88 percent of patients reporting they were very satisfied.

³⁴

Whether robotic assistance translates into meaningfully better long-term outcomes for patients, fewer revisions, lower dislocation rates, better function at ten or twenty years, remains unproven. The technology is still maturing, and the data so far mostly concern implant positioning accuracy rather than the clinical endpoints patients care about most. It is reasonable to view robotics as a precision tool that may narrow the margin of surgical error, while recognizing that surgeon experience and patient factors still dominate the outcome equation.

An Evolutionary Footnote

It is worth noting that hip osteoarthritis is, in some sense, a byproduct of being human. The hip joint we walk on was shaped by the evolutionary transition to permanent upright walking. A large genetic study identified specific genetic variants linked to skeletal shape that also increase the risk of hip and knee osteoarthritis. These variants were enriched in so-called human accelerated regions of the genome, stretches of DNA that changed rapidly during human evolution, tying the very anatomy that makes us bipedal to the disease process.

³⁵

Even the cam deformity that causes femoroacetabular impingement has evolutionary roots. The human femoral head evolved to be spherical for upright walking. But high-impact sport during adolescence can activate underlying genetic programs that reinforce the femoral neck, creating a bump of extra bone that resembles the naturally aspherical hips of four-legged animals, except positioned on the front of the bone rather than the back, reflecting the difference in how we bear weight compared to quadrupeds. That extra bone then grinds against the acetabular rim during hip flexion, slowly damaging cartilage and setting the stage for osteoarthritis decades later.

³⁶